On Thursday, Jan. 22, 2026, Cathie Wood-led Ark Invest bought $2.4 million in Tempus AI and WeRide while selling $1.6 million in Roku amid mixed analyst signals.

Hims & Hers and Tempus AI are transforming digital health in distinct ways, but which platform looks more compelling right ...

Netflix has surrendered $82 billion in market cap since it was crowned the victor in the Warner Bros. Discovery sweepstakes, ...

Tempus AI's diagnostics segment shows strong pricing power, with Oncology ASP rising from $1,630 to over $2,200. Read why TEM ...

Following the acquisition of Paige in 2025, Tempus launches its new AI-powered, biomarker prediction solution for digital ...

Chicago artificial intelligence giant Tempus AI is showing it's operating in the black after 10 years and growing.

The data provider's artificial intelligence-driven solutions are accelerating drug discovery.

Tempus AI stock remains in a bear market after crashing by 36% from its highest point in September last year. What next for ...

Tempus, a leader in artificial intelligence and precision medicine, and NYU Langone Health, one of the nation's premier academic medical centers, today announced a multi-year strategic collaboration ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a record Total Contract Value (TCV) of >$1.1 billion as of December 31, ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced select, preliminary, unaudited results for the fourth quarter and full ...

As a founding growth leader who shaped Tempus' early momentum, Amy Gordon Franzen will help Rune Labs scale the first and largest AI neurology platform to all neurology Rune Labs, the leader in ...